z-logo
open-access-imgOpen Access
A Phase II Study of Sirolimus-Based Calcineurin Inhibitor-Free Gvhd Prophylaxis after Peripheral Blood Haploidentical Transplantation with Post-Transplant Cyclophosphamide
Author(s) -
Nelli Bejanyan,
Joseph A. Pidala,
Xuefeng Wang,
Ram Thapa,
Taiga Nishihori,
Hany Elmariah,
Aleksandr Lazaryan,
Farhad Khimani,
Marco L. Davila,
Asmita Mishra,
Rawan Faramand,
Michael D. Jain,
Leonel Ochoa,
Lia Perez,
Hien Liu,
Melissa Alsina,
Mohamed A. KharfanDabaja,
Hugo F. Fernández,
Michael L. Nieder,
Frederick L. Locke,
Daniel M. Sullivan,
Claudio Anasetti,
Ernesto Ayala
Publication year - 2020
Publication title -
biology of blood and marrow transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.301
H-Index - 120
eISSN - 1523-6536
pISSN - 1083-8791
DOI - 10.1016/j.bbmt.2019.12.133
Subject(s) - medicine , busulfan , fludarabine , calcineurin , cumulative incidence , cyclophosphamide , sirolimus , transplantation , gastroenterology , tacrolimus , surgery , chemotherapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom